Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-307866
Filing Date
2013-07-30
Accepted
2013-07-29 18:38:38
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d552758d10q.htm 10-Q 962510
2 EX-31.1 d552758dex311.htm EX-31.1 6656
3 EX-31.2 d552758dex312.htm EX-31.2 6668
4 EX-32.1 d552758dex321.htm EX-32.1 3589
5 EX-32.2 d552758dex322.htm EX-32.2 3607
  Complete submission text file 0001193125-13-307866.txt   12083827

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT act-20130630.xml EX-101.INS 1291973
7 XBRL TAXONOMY EXTENSION SCHEMA act-20130630.xsd EX-101.SCH 68150
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE act-20130630_cal.xml EX-101.CAL 88686
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE act-20130630_def.xml EX-101.DEF 200409
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE act-20130630_lab.xml EX-101.LAB 495506
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE act-20130630_pre.xml EX-101.PRE 336900
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
Actavis, Inc. (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 13993708
SIC: 2834 Pharmaceutical Preparations